gammaCore, a handheld device used to alleviate cluster headaches, is now availble through NHS England following successful trials.
The roll out of the medical device is supported by the Medtech Funding Mandate, which fast-tracks innovations in the NHS. This mandate is part of the NHS Long Term Plan and came into effect on 1 April 2021.
WHY IT MATTERS
gammaCore works to relieve pain by delivering low-level electrical currents that block pain signals when held against the neck.
Cluster headaches affect approximately 11,000 people in the UK, mainly men who begin experiencing them in their 30s or 40s. These types of headaches set on quickly and can last between 15 minutes and 3 hours, occurring as many as eight times a day.
Patients will be able to use gammaCore regularly to relieve headaches or prevent their onset by using the device when they...